Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Radiotherapy. Found 48 abstracts

no pagination
Kishan AU, Shaikh T, Wang PC, Reiter RE, Said J, Raghavan G, Nickols NG, Aronson WJ, Sadeghi A, Kamrava M, Demanes DJ, Steinberg ML, Horwitz EM, Kupelian PA, King CR. Clinical Outcomes for Patients with Gleason Score 9-10 Prostate Adenocarcinoma Treated With Radiotherapy or Radical Prostatectomy: A Multi-institutional Comparative Analysis. Eur Urol. 2017 May;71(5):766-73.
Zaorsky NG, Williams GR, Barta SK, Esnaola NF, Kropf PL, Hayes SB, Meyer JE. Splenic irradiation for splenomegaly: A systematic review. Cancer Treat Rev. 2017 Feb;53:47-52.
Schiech L. Tonsillar cancer: What nurses need to know. Nursing. 2016 Jul;46(7):36-44.
Zaorsky NG, Williams GR, Barta SK, Esnaola NF, Kropf PL, Hayes SB, Meyer JE. Splenic irradiation for splenomegaly: A systematic review. Cancer Treat Rev. 2016 Dec 22;53:47-52.
Zaorsky NG, Williams GR, Barta SK, Esnaola NF, Kropf PL, Hayes SB, Meyer JE. Splenic irradiation for splenomegaly: A systematic review. Cancer Treat Rev. 2016 Dec 22;53:47-52.
Hamstra DA, Bae K, Hanks G, Hu C, Shipley WU, Pan CC, Roach M, Lawton CA, Sandler HM. Impact of Biochemical Failure Classification on Clinical Outcome: A Secondary Analysis of Radiation Therapy Oncology Group 9202 and 9413. Cancer. 2015 Mar;121(6):844-52.   PMCID: 4657945
Bagshaw H, Ruth K, Horwitz EM, Chen DY, Buyyounouski MK. Does family history of prostate cancer affect outcomes following radiotherapy?. Radiotherapy and Oncology. 2014 Feb;110(2):229-34.   PMCID: 3991234
Yang B, Wei XD, Zhao YT, Ma CM. Dosimetric evaluation of integrated IMRT treatment of the chest wall and supraclavicular region for breast cancer after modified radical mastectomy. Medical Dosimetry. 2014 Jan;39(2):185-9.   PMCID: No NIH funding
Yang B, Wei XD, Zhao YT, Ma CM. Dosimetric evaluation of integrated IMRT treatment of the chest wall and supraclavicular region for breast cancer after modified radical mastectomy. Med Dosim. 2014 Jan;39(2):185-9.
Abrams RA, Winter KA, Regine WF, Safran H, Hoffman JP, Lustig R, Konski AA, Benson AB, Macdonald JS, Rich TA, Willett CG. FAILURE TO ADHERE TO PROTOCOL SPECIFIED RADIATION THERAPY GUIDELINES WAS ASSOCIATED WITH DECREASED SURVIVAL IN RTOG 9704-A PHASE III TRIAL OF ADJUVANT CHEMOTHERAPY AND CHEMORADIOTHERAPY FOR PATIENTS WITH RESECTED ADENOCARCINOMA OF THE PANCREAS. International Journal of Radiation Oncology Biology Physics. 2012 Feb;82(2):809-16.   PMCID: PMC133855
Davis BJ, Horwitz EM, Lee WR, Crook JM, Stock RG, Merrick GS, Butler WM, Grimm PD, Stone NN, Potters L, Zietman AL, Zelefsky MJ. American Brachytherapy Society consensus guidelines for transrectal ultrasound-guided permanent prostate brachytherapy. Brachytherapy. 2012 Jan;11(1):6-19.   PMCID: not NIH funded
Wong SJ, Winter K, Meropol NJ, Anne PR, Kachnic L, Rashid A, Watson JC, Mitchell E, Pollock J, Lee RJ, Haddock M, Erickson BA, Willett CG. RADIATION THERAPY ONCOLOGY GROUP 0247: A RANDOMIZED PHASE II STUDY OF NEOADJUVANT CAPECITABINE AND IRINOTECAN OR CAPECITABINE AND OXALIPLATIN WITH CONCURRENT RADIOTHERAPY FOR PATIENTS WITH LOCALLY ADVANCED RECTAL CANCER. International Journal of Radiation Oncology Biology Physics. 2012 Mar;82(4):1367-75.   PMCID: PMC3208721
Klayton TL, Ruth K, Horwitz EM, Uzzo RG, Kutikov A, Chen DY, Sobczak M, Buyyounouski MK. Young age under 60 years is not a contraindication to treatment with definitive dose escalated radiotherapy for prostate cancer. Radiotherapy and Oncology. 2011 Dec;101(3):508-12.   PMCID: PMC3225561
Ma CM, Luxton G, Orton CG. Point/counterpoint: pulsed reduced dose rate radiation therapy is likely to become the treatment modality of choice for recurrent cancers. Med Phys. 2011 Sep;38(9):4909-11.   PMCID: not NIH funded
Buyyounouski MK. Androgen deprivation therapy in high-risk prostate cancer. Oncology (Williston Park). 2010 Aug;24(9):806, 809.   PMCID: Not NIH funded
Chen LL, Paskalev K, Xu X, Zhu J, Wang L, Price RA, Hu W, Feigenberg SJ, Horwitz EM, Pollack A, Ma CM. Rectal dose variation during the course of image-guided radiation therapy of prostate cancer. Radiotherapy and Oncology. 2010 May;95(2):198-202.   PMCID: not NIH funded
Park CC, Yom SS, Podgorsak MB, Harris E, Price RA, Bevan A, Pouliot J, Konski AA, Wallner PE, Elect Brachytherapy Working Grp. AMERICAN SOCIETY FOR THERAPEUTIC RADIOLOGY AND ONCOLOGY (ASTRO) EMERGING TECHNOLOGY COMMITTEE REPORT ON ELECTRONIC BRACHYTHERAPY. International Journal of Radiation Oncology Biology Physics. 2010 Mar;76(4):963-72.   PMCID: not NIH funded
Lally BE, Geiger AM, Urbanic JJ, Butler JM, Wentworth S, Perry MC, Wilson LD, Horton JK, Detterbeck FC, Miller AA, Thomas CR, Blackstock AW. Trends in the outcomes for patients with limited stage small cell lung cancer: An analysis of the Surveillance, Epidemiology, and End Results database. Lung Cancer. 2009 Jan;64(2):226-31.   PMCID: NIHMS117386
Zhang M, Ho A, Hammond EH, Suzuki Y, Bermudez RS, Lee RJ, Pilepich M, Shipley WU, Sandler H, Khor LY, Pollack A, Chakravarti A. Prognostic value of surviving in locally advanced prostate cancer: study based on RTOG 8610. International Journal of Radiation Oncology Biology Physics. 2009 Mar;73(4):1033-42.   PMCID: PMC 2678565
Bleicher RJ, Topham NS, Morrow M. Beauty and the beast: management of breast cancer after plastic surgery. Ann Surg. 2008 Apr;247(4):680-6.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Radiotherapy

Radiotherapy radiotherapy Cancer therapy Dosimetry Splenomegaly Toxicity Radiation oncology Palliation Middle Aged Leukemia Prostate cancer Myelofibrosis adverse effects Lymphoma Aged Meta-analysis Oncology Male trial Nuclear Medicine & Medical Imaging Radiology Radiation Dosage Breast Neoplasms Treatment Outcome Recurrence pathology methods Dose Fractionation Prostate Breast cancer Female Quality assurance Prostatic Neoplasms Perioperative Nursing Combined Modality Therapy Neoplasm Metastasis seed implantation i complications Standard re-optimization biochemical failure Papillomaviridae Neoplasms Radiation breast-cancer chemoradiotherapy FAILURE risk IN-VIVO Clinical trials Imrt rates Survivin postimplant united-states Elderly acute urinary Radical prostatectomy hospital volume ii stage breast-cancer escalation prostate-specific antigen failure rectal-cancer MESSENGER-RNA Mastectomy phase-iii trial boost ANTI-APOPTOSIS GENE experience Spleen dosimetric analysis Palatine Tonsil Kallikreins postoperative radiotherapy nursing Adult CELL-PROLIFERATION Chemoradiotherapy Rectal GASTRIC CARCINOMAS epidemiology interoperative Survival Analysis critical-appraisal Conformal preoperative radiotherapy HEPATOCELLULAR-CARCINOMA external-beam radiation Family history Prognostic factor blood surgery Chemotherapy ADJUVANT CHEMOTHERAPY 80 and over Aged Guideline pubic arch interference intraoperative radiotherapy iort IRRADIATION Rectal dose Local Neoplasm Recurrence Carcinoma quality-of-life SPLICE VARIANTS mortality Clinical Trials as Topic Proportional Hazards Models Hematologic Neoplasms Safety body-mass index Young Adult Gleason 9 chemotherapy Nursing Diagnosis 1980 aryulu kkn-international journal of radiation oncology biology physics-v6-p1261 Intensity-Modulated Radiotherapy terminology target localization androgen deprivation therapy Interstitial Radiotherapy Dosage Electronic Brachytherapy men younger POSTMASTECTOMY Radiation therapy errors RADIATION-THERAPY retention competing group protocol 92-02 EXPRESSION Prognosis Course of treatment Tonsillectomy radiation effects Pancreatic adenocarcinoma Small cell lung cancer external-beam radiotherapy Mammaplasty Androgen Antagonists chemoradiation androgen deprivation RADIOTHERAPY setup diagnosis chemically induced Treatment Failure IGRT
Last updated on Wednesday, September 06, 2017